Vivos Therapeutics, Inc. (VVOS)
NASDAQ
Vivos Therapeutics, Inc. Total Liabilities 2019–2025
Vivos Therapeutics, Inc. annual total liabilities history from 2019 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Vivos Therapeutics, Inc. total liabilities as of December 31, 2025: 26.7M, a 264.28% increase year-over-year.
- Vivos Therapeutics, Inc. total liabilities for 2025 were 26.7M, a 264.28% increase from 2024.
- Vivos Therapeutics, Inc. total liabilities for 2024 were 7.3M, a 28.97% decrease from 2023.
- Vivos Therapeutics, Inc. total liabilities for 2023 were 10.3M, a 15.70% increase from 2022.
- Vivos Therapeutics, Inc. total liabilities for 2022 were 8.9M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Vivos Therapeutics, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $27 |
| 2024 | $7 |
| 2023 | $10 |
| 2022 | $9 |
| 2021 | $8 |
| 2020 | $8 |
| 2019 | $9 |
Vivos Therapeutics, Inc. Total Liabilities — FAQ
Vivos Therapeutics, Inc. (VVOS) total liabilities over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VVOS's total liabilities history?
The chart and table above show Vivos Therapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.